| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 07/22/2004 | CA2515518A1 Irs modulators |
| 07/22/2004 | CA2513627A1 Anti-inflammatory medicaments |
| 07/22/2004 | CA2512735A1 Eye-drop vaccine containing copolymer 1 for therapeutic immunization |
| 07/22/2004 | CA2512052A1 Human growth hormone crystals and methods for preparing them |
| 07/22/2004 | CA2511879A1 Methods of treating and/or preventing autoimmune diseases |
| 07/22/2004 | CA2511873A1 Modulation of protein functionalities |
| 07/22/2004 | CA2511838A1 Uses of mammalian cytokine; related reagents |
| 07/22/2004 | CA2511817A1 Novel compositions and methods in cancer |
| 07/22/2004 | CA2511816A1 Methods and compositions for the diagnosis, prognosis, and treatment of cancer |
| 07/22/2004 | CA2511646A1 Thiosemicarbazones as anti-virals and immunopotentiators |
| 07/22/2004 | CA2511513A1 Methods of inducing and maintaining immune tolerance |
| 07/22/2004 | CA2508726A1 Methods for rapid identification of pathogens in humans and animals |
| 07/21/2004 | EP1439177A1 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane |
| 07/21/2004 | EP1438965A1 Use of extracts from Hoodia gordonii and Hoodia lugardii for the preparation of a medicament for use in the suppression of appetite |
| 07/21/2004 | EP1438959A1 Controlled release oxycodone compositions |
| 07/21/2004 | EP1438418A2 Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| 07/21/2004 | EP1438291A1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 07/21/2004 | EP1438037A1 Methods for treating dry eye by a combination of an antiinflammatory steroid and a muc-1 secretagogue |
| 07/21/2004 | EP1228029B1 Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders |
| 07/21/2004 | EP1226137B1 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
| 07/21/2004 | CN1514828A Pyrazole derivatives for treating HIV |
| 07/21/2004 | CN1514716A Breath protection microcapsules |
| 07/21/2004 | CN1158276C Phenyl-and pyridyl-tetrahydro-pyridines having TNF inhibiting activity |
| 07/21/2004 | CN1158074C Pharmaceutical compositions of tizoxanide and nitazoxanide |
| 07/21/2004 | CN1158071C Multi-layered osmotic device |
| 07/21/2004 | CN1158070C Immediate release tablet |
| 07/20/2004 | US6765000 For therapy of symptoms associated in humans with reactive arthritis (spondyloarthritity) or idiopathic bursitis |
| 07/20/2004 | US6764687 Live attenuated bacteria for use in a vaccine |
| 07/20/2004 | US6764678 Local anesthetic methods and kits |
| 07/20/2004 | CA2216634C Synergistic combinations of zidovudine, 1592u89 and 3tc or ftc |
| 07/15/2004 | WO2004058803A2 Peptides that bind of the vegfr-2 |
| 07/15/2004 | WO2004058329A2 Ester combination local anesthetic |
| 07/15/2004 | WO2004058270A1 3-(3,5-dioxo-4,5-dihydro-3h-(1,2,4)triazin-2-yl)-benzamide derivatives as p2x7-inhibitors for the treatment of inflammatory diseases |
| 07/15/2004 | WO2004058191A2 Multivalent lymphotoxin beta receptor agonists and therapeutic uses thereof |
| 07/15/2004 | WO2004058190A2 Methods for treating taxol-induced sensory neuropathy |
| 07/15/2004 | WO2004058188A2 Vaccine compositions and methods |
| 07/15/2004 | WO2004058183A2 Lymphotoxin beta receptor agents in combination with chemotherapeutic agents |
| 07/15/2004 | WO2004058180A2 Intraoral calculus dissolving gel composition |
| 07/15/2004 | WO2004058178A2 Uses of mammalian cytokine; related reagents |
| 07/15/2004 | WO2004058175A2 Novel use of liver x receptor agonists |
| 07/15/2004 | WO2004058173A2 Method and apparatus of sterilizing internal passages of a centrifuge centrate gate |
| 07/15/2004 | WO2004058172A2 Enhanced gaming system |
| 07/15/2004 | WO2004058167A2 Breast specific protein expressed in cancer and methods of use thereof |
| 07/15/2004 | WO2004058159A2 Branched immunomodulatory compounds and methods of using the same |
| 07/15/2004 | WO2004058148A2 Mitotic kinesin inhibitors |
| 07/15/2004 | WO2004058144A2 Antibacterial agents |
| 07/15/2004 | WO2004058142A2 Improved combine vaccine against mycoplasma hyopneumoniae and porcine viruses |
| 07/15/2004 | WO2004045561A3 Use of ferritin for immunomodulation |
| 07/15/2004 | WO2004045537A3 Edible film for relief of cough or symptoms associated with pharyngitis |
| 07/15/2004 | WO2004045505A3 Extract of stephaniae sinica diels and methods of using the same |
| 07/15/2004 | WO2004043333A3 Bone enhancing composite |
| 07/15/2004 | WO2004041187A3 Compositions and methods for transdermal oxybutynin therapy |
| 07/15/2004 | WO2004041186A3 Anti-angiogenesis effects of morinda citrifolia |
| 07/15/2004 | WO2004039329A3 Treatment of immunological renal disorders by lymphotoxin pathway inhibitors |
| 07/15/2004 | WO2004039328A3 Fludrocortisone treatment for hearing loss |
| 07/15/2004 | WO2004037190A3 Modified release compositions of milnacipran |
| 07/15/2004 | WO2004034987A3 Treatment for reactive arthritis or bursitis |
| 07/15/2004 | WO2004034956A3 8-plasmid method with mutated ha gene for producing an influenza vaccine |
| 07/15/2004 | WO2004028463A3 Methods and compositions for the treatment of lupus using clofarabine |
| 07/15/2004 | WO2004026260A3 Prophylactic and therapeutic hiv aptamers |
| 07/15/2004 | WO2004026248A3 Octahydro-2-h-naphtho[1,2-f] indole-4-carboxamide derivatives as selective glucocorticoid receptor modulators |
| 07/15/2004 | WO2003099209A3 Compositions and methods for screening and identifying anti-hcv agents |
| 07/15/2004 | US20040138709 Regulation of matrix metalloproteinase gene expression using specific and selective electrical and electromagnetic signals |
| 07/15/2004 | US20040138647 Cycle mode providing redundant back-up to ensure termination of treatment therapy in a medical device system |
| 07/15/2004 | US20040138603 Ultra thin film transdermal/dermal or transmucosal/mucosal delivery system |
| 07/15/2004 | US20040138299 Dispersion of bicalutamide for prostate cancer treatment |
| 07/15/2004 | US20040138267 Antitumor agents |
| 07/15/2004 | US20040138220 Central nervous system disorder; gastrointestinal disorders; asthma; skin disorders; inflammatory bowel disorders; analgesics |
| 07/15/2004 | US20040138165 Nucleic acids; drug or gene product; stabilization; gene therapy; purification using free radical scavenger |
| 07/15/2004 | US20040138164 Oligonucleotides; nucleic acid; therapy, diagnosis; cardiovascular disorders, atherosclerosis, anticholesterol agents |
| 07/15/2004 | US20040138134 Method and composition for treatment of skeletal dysplasias |
| 07/15/2004 | US20040137523 Method of isolation and self-assembly of small protein particles from blood and other biological materials |
| 07/15/2004 | US20040137472 identifying a compound capable of modulating a splicing event in a pre-mRNA molecule using a cDNA incapable of gene expression in the absence of modulation of a splicing event; using compound(s) identified to treat genetic disorders |
| 07/15/2004 | US20040137051 Wound healing compositions and methods of use |
| 07/15/2004 | US20040137010 gp120 and a nucleic acid aptamer that binds to gp120 and induces gp120 to undergo a conformational shift whereby an epitope to a membrane bound receptor is exposed that is capable of eliciting a humoral immune response |
| 07/15/2004 | US20040136991 Treatment of anemia using TNFalpha inhibitors |
| 07/15/2004 | US20040136990 Treatment of pain using TNFalpha inhibitors |
| 07/15/2004 | US20040136989 Kawasaki's Disease; Behcet's disease; TNF alpha antibody, or an antigen-binding fragment |
| 07/15/2004 | US20040136973 Human stem cell materials and methods |
| 07/15/2004 | US20040136955 Modified asialo-interferons and uses thereof |
| 07/15/2004 | US20040136948 Branched immunomodulatory compounds and methods of using the same |
| 07/15/2004 | US20040136923 Edible film for relief of cough or symptoms associated with pharyngitis |
| 07/15/2004 | US20040136920 aerosol formulation which comprises particulate salbutamol or a physiologically acceptable salt or solvate thereof and 1,1,1,2-tetrafluoroethane as propellant, which formulation is substantially free of surfactant |
| 07/15/2004 | CA2511295A1 Methods for treating taxol-induced sensory neuropathy |
| 07/15/2004 | CA2511013A1 Multivalent lymphotoxin beta receptor agonists and therapeutic uses thereof |
| 07/15/2004 | CA2510314A1 Breast specific protein expressed in cancer and methods of use thereof |
| 07/15/2004 | CA2510173A1 Vaccine compositions and methods |
| 07/15/2004 | CA2509495A1 Lymphotoxin beta receptor agents in combination with chemotherapeutic agents |
| 07/15/2004 | CA2509212A1 Mitotic kinesin inhibitors |
| 07/15/2004 | CA2508985A1 Branched immunomodulatory compounds and methods of using the same |
| 07/15/2004 | CA2507511A1 Ester combination local anesthetic |
| 07/14/2004 | EP1436006A2 Viral inhibition by n-docosanol |
| 07/14/2004 | EP1435937A2 Composition comprising paracetamol and a bitterness masking component |
| 07/14/2004 | EP1435826A2 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 07/14/2004 | EP1228067B1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 07/14/2004 | EP1224179B1 Sodium-hydrogen exchanger type 1 inhibitor crystals |
| 07/14/2004 | EP1140102B1 Triazineone compounds for treating diseases due to neospora and toxoplasma |
| 07/14/2004 | EP0824588B1 Il-6 activity inhibitor |
| 07/14/2004 | CN1512985A Aimoquinoline and aminopyridine derivatives and their use as adenosine A3 ligands |
| 07/14/2004 | CN1157392C 8-Azabicyclo (3,2,1) oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ACH receptors |